Medical Image Analysis Software Market
Medical Image Analysis Software Market by Function (Reconstruction, Detection, Analysis, Reporting), Tech (AI [ML, Computer Vision), Image (3D, 4D), Modality (CT, PET/SPECT, Mammo), Indication (Onco, Cardio), End User (Hospital) - Global Forecast to 2031
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global medical image analysis software market is projected to grow from USD 4.35 billion in 2026 to USD 6.42 billion by 2031, at a CAGR of 8.1% during the forecast period. The market was valued at USD 4.04 billion in 2025. The growth of the medical image analysis software market is driven by the increasing need to reduce radiologist workload, improve diagnostic turnaround time, and manage rising imaging volumes across hospitals, diagnostic centers, and research institutions. Healthcare organizations are adopting AI-enabled software for image detection, segmentation, reconstruction, registration, reporting, and clinical decision support across CT, MRI, ultrasound, mammography, and nuclear imaging.
KEY TAKEAWAYS
-
MARKET SNAPSHOT:
Base Year Market Size (2025): USD 4.04 Billion
Current Market Size (2026): USD 4.35 Billion
Forecast Market Size (2031): USD 6.42 Billion
CAGR (2026–2031): 8.1% -
SEGMENT LEADERSHIP:
Regional Leader: North America dominated the market with a share of 38.4% in 2025.
Software Leader: Integrated software segment held the largest market share of 64.5% in 2025.
Technology Leader: AI-enabled technology segment is expected to register the highest CAGR of 8.6% during the forecast period.
Detection & Localization: The detection & localization segment is expected to register the highest CAGR during the forecast period.
Imaging Leader: 3D imaging segment accounted for the largest market share in 2025.
Imaging Modality Leader: Computed tomography (CT) segment held the largest market share in 2025.
Application Leader: Cardiology segment held the largest market share in 2025.
End User Leader: Hospitals segment held the largest market share in 2025, while diagnostic imaging centers segment is expected to register the highest CAGR during the forecast period. -
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
Siemens Healthineers AG, GE HealthCare, and Koninklijke Philips N.V. were identified as some of the star players in the medical image analysis software market, given their strong market share and product footprint.
Viz.ai, Inc. and Aidoc Medical have distinguished themselves among startups and SMEs by establishing strong footholds in specialized niches, underscoring their potential as emerging market leaders.
Demand for medical image analysis software is growing as hospitals and diagnostic centers look to reduce radiologist workload and improve diagnostic turnaround time. It supports functions such as detection & localization, segmentation & analysis, reconstruction & visualization, registration & comparison, reporting & communication, and clinical decision support.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
Trend disruption in the medical image analysis software market is mainly driven by the shift from conventional, rule-based image processing to AI-enabled detection, deep learning reconstruction, cloud-native platforms, and integrated hardware-software models. Hospitals, diagnostic imaging centers, and research institutions are using AI-based software to reduce manual review time in detection & localization, segmentation & analysis, reconstruction & visualization, reporting & communication, and clinical decision support across CT, MRI, ultrasound, and mammography. This trend is improving diagnostic turnaround time, reducing missed findings, lowering radiologist workload, and increasing consistency across image interpretation workflows. AI-based triage, automated lesion detection, deep learning reconstruction, and cloud-enabled enterprise imaging are changing how healthcare organizations manage diagnostic operations. In December 2024, the FDA finalized guidance on Predetermined Change Control Plans, letting AI software makers pre-authorize future updates instead of filing new submissions each time. Major players such as Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, and Aidoc Medical Ltd. are contributing to this shift through AI-enabled hardware integration, cloud platforms, strategic acquisitions, and vendor-neutral algorithm marketplaces.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Rising imaging volumes amid growing radiologist workforce shortages
-
Increasing FDA and regulatory clearances for AI-enabled imaging software
Level
-
High cost of software validation, integration, and deployment
-
Data privacy and cross-border health data regulations
Level
-
Expansion of cloud-native and AI-as-a-service imaging platforms
-
Emerging applications of foundation models and multimodal AI in diagnostic imaging
Level
-
Limited interoperability with legacy PACS/RIS and vendor-specific systems
-
Algorithm generalizability and bias across diverse patient populations
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Rising imaging volumes amid growing radiologist workforce shortages
According to the American Journal of Roentgenology, US imaging volume is rising by roughly 5% annually, while the American College of Radiology recorded 1,900 radiology job postings in January 2025 alone. Only about 1,000 new radiologists enter the US workforce each year, well short of demand. This imbalance is forcing hospitals to rely on AI software to triage, prioritize, and pre-screen scans before radiologist review. The gap is even wider in emerging markets, where rural regions often have fewer than one radiologist per 100,000 people. As imaging demand keeps outpacing radiologist supply, AI-enabled detection and workflow software is becoming essential rather than optional.
Restraint: High cost of software validation, integration, and deployment
Clinically validating AI algorithms against diverse patient populations requires large annotated datasets and multi-site studies, which is expensive and time-consuming. Integrating new AI tools with existing PACS/RIS infrastructure often requires custom IT work and ongoing technical support. Smaller hospitals and diagnostic centers frequently lack the budget or in-house IT staff to manage this integration burden. Total cost of ownership includes not just licensing fees but also validation, training, and workflow redesign. These costs can slow or block adoption, particularly outside large, well-funded hospital systems.
Opportunity: Expansion of cloud-native and AI-as-a-service imaging platforms
Cloud-based deployment models are lowering the upfront cost barrier for hospitals to access AI imaging tools without large on-premises infrastructure investment. Vendor-neutral platforms are allowing hospitals to run multiple AI algorithms from different companies on a single infrastructure layer. This model supports faster scaling across multi-site hospital networks and teleradiology providers. Subscription-based pricing is also making advanced AI tools more accessible to smaller diagnostic centers. As cloud infrastructure matures, AI-as-a-service is expected to become a preferred deployment model over traditional on-premises software.
Challenge: Limited interoperability with legacy PACS/RIS and vendor-specific systems
Many hospitals still operate on older PACS/RIS systems that were not designed to integrate with modern AI software. Vendor-specific data formats and proprietary architectures make it difficult to deploy AI tools across multi-vendor imaging environments. This fragmentation forces hospitals to either limit AI adoption to compatible systems or invest in costly infrastructure upgrades. Enterprise imaging vendors are working to build more open, vendor-neutral platforms, but full interoperability remains uneven across the industry. Until legacy system compatibility improves, this remains a practical barrier to widescale AI deployment.
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides an AI-enabled radiology services suite covering scheduling, image acquisition, and automated reporting | Reduces reporting time and improves consistency of image interpretation |
 |
Combines its AI imaging portfolio with Intelerad's cloud and AI orchestration capabilities to deliver connected imaging software across care settings | Expands cloud-enabled imaging access and improves radiology workflow efficiency |
 |
Offers Philips Verida, the world's first detector-based Spectral CT fully powered by AI, and Philips Vue PACS, a web-based diagnostic viewer | Improves diagnostic image quality and enables remote study access without dedicated software |
 |
Provides Precise IQ Engine, an AI deep learning reconstruction technology under its Altivity AI brand for high-resolution CT imaging | Improves image resolution at lower radiation dose and standardizes imaging protocols |
 |
Offers REiLI, a vendor-neutral AI platform integrated into Synapse PACS that hosts both Fujifilm and third-party AI algorithms | Lets hospitals run multiple vendors' AI tools on one platform, speeding up reporting |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The medical image analysis software ecosystem includes imaging equipment manufacturers, AI software vendors, hospitals and diagnostic imaging centers, academic and research institutions, PACS/RIS and IT integration partners, cloud service providers, and regulatory/compliance bodies. Imaging equipment manufacturers help healthcare organizations combine hardware and AI software for detection & localization, segmentation & analysis, reconstruction & visualization, registration & comparison, and reporting & communication across CT, MRI, ultrasound, and mammography. Hospitals use image analysis software to reduce radiologist workload, improve diagnostic turnaround time, and support clinical decision-making across cardiology, oncology, and neurology. Diagnostic imaging centers use AI-based triage and reporting tools to manage high patient volumes and support remote and teleradiology reading models. Academic and research institutions use imaging AI software for multi-center clinical studies and disease-specific research as imaging datasets grow larger. AI and cloud technology vendors support the ecosystem by enabling deep learning algorithms, vendor-neutral AI platforms, cloud-native deployment, and workflow automation. Regulatory bodies such as the FDA, EMA, and China's NMPA shape the ecosystem through device clearance pathways, AI update frameworks, and data privacy requirements that govern how imaging software reaches clinical use.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Medical Image Analysis Software Market, by Type
The integrated software segment held the largest share of the medical image analysis software market in 2025, as imaging equipment manufacturers such as Siemens Healthineers AG and Koninklijke Philips N.V. increasingly bundle AI directly into CT, MRI, and X-ray systems. Hospitals prefer integrated software because it eliminates separate installation, licensing, and vendor management. The segment remains largest because equipment makers use bundled AI to strengthen customer retention and build recurring software revenue. Standalone software, offered by vendor-neutral AI companies, is expected to grow steadily as hospitals seek algorithms that work across multiple scanner brands.
Medical Image Analysis Software Market, by Technology
During the forecast period, AI-enabled technology is expected to grow the fastest, as healthcare providers seek to automate image interpretation and manage rising imaging volumes. Deep learning, computer vision, and machine learning are increasingly incorporated into software for automated analysis, abnormality detection, and quantitative assessment. AI-based tools can reduce repetitive tasks for radiologists, improve workflow efficiency, and support faster interpretation of complex imaging studies. The increasing availability of AI-enabled solutions for early disease detection, image segmentation, triage, and clinical decision support is further supporting adoption
Medical Image Analysis Software Market, by Function
The reconstruction & visualization segment held the largest share of the medical image analysis software market in 2025, as radiology departments rely heavily on tools that improve image clarity and reduce radiation dose during CT and MRI scans. Detection & localization is expected to register the fastest growth during the forecast period. This is because AI-based detection tools directly address radiologist shortages by flagging urgent findings for priority review. As hospitals prioritize faster triage of critical cases, detection & localization software is becoming a leading area of adoption.
Medical Image Analysis Software Market, by Image Type
During the forecast period, the 4D imaging segment is expected to register the fastest growth, driven by the increasing adoption of dynamic, time-resolved imaging for more comprehensive visualization and quantitative analysis of anatomical structures and physiological processes. The growing use of 4D imaging in cardiac MRI, 4D flow MRI, and 3D/4D ultrasound is further supporting segment growth, particularly for cardiovascular assessment and functional analysis. In addition, the availability of advanced software solutions for 4D visualization, segmentation, flow quantification, and automated analysis is improving the clinical utility of 4D imaging.
Medical Image Analysis Software Market, by Modality
During the forecast period, ultrasound imaging is expected to experience the fastest growth, supported by the increasing use of AI-assisted ultrasound for image acquisition, optimization, measurement, and interpretation. AI-enabled ultrasound technologies can assist clinicians with standardized imaging and automated assessment, expanding the role of software in point-of-care and diagnostic workflows.
Medical Image Analysis Software Market, by Therapeutic Area
The cardiology segment held the largest share of the market in 2025, as AI-based CT and echocardiography analysis tools are widely used for coronary artery disease detection and cardiac risk assessment. Oncology is expected to register the fastest growth during the forecast period. Oncology is growing quickly because AI-based tumor detection, measurement, and treatment-response tracking support earlier cancer diagnosis and more precise treatment planning. As cancer incidence rises globally, oncology imaging software is becoming a major area of vendor investment.
Medical Image Analysis Software Market, by End User
During the forecast period, diagnostic imaging centers are expected to experience the fastest growth, supported by rising imaging volumes, demand for faster reporting, and increasing adoption of AI-assisted analysis. Automated detection, segmentation, quantification, and workflow tools can help imaging centers manage high case volumes and improve operational efficiency. The growing use of outpatient imaging and specialized diagnostic services is increasing the need for scalable image analysis solutions. AI-enabled tools can also help standardize image interpretation, prioritize critical cases, and reduce turnaround times for diagnostic reports.
REGION
Asia Pacific region is expected to register the fastest growth in the medical image analysis software market during the forecast period
The Asia Pacific market is anticipated to grow at the fastest CAGR during the forecast period, supported by rapid healthcare digitization, increasing diagnostic imaging volumes, expanding healthcare infrastructure, and growing adoption of AI-enabled medical technologies. Countries such as China, Japan, India, South Korea, and Australia are increasing the use of AI-assisted imaging for detection, image analysis, clinical decision support, and workflow automation. In November 2025, China’s National Health Commission issued guidance supporting AI applications in medical imaging, including assisted diagnosis, automated reporting, image-quality evaluation, and treatment recommendations, with broader adoption targeted across secondary and tertiary hospitals by 2030. In January 2026, FUJIFILM India introduced AI-enabled CT, mammography, radiography, and healthcare IT solutions to help radiology departments manage rising imaging volumes and diagnostic complexity.
MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPANY EVALUATION MATRIX
In the medical image analysis software market matrix, Siemens Healthineers AG (Star) leads with its strong portfolio of AI-enabled imaging and clinical decision-support solutions, including AI-Rad Companion across CT, MRI, and X-ray applications. Its deep integration of AI into imaging workflows, automated segmentation and measurements, and broad installed base of imaging systems strengthen its position in the market. Microsoft Corporation (Emerging Leader) is gaining traction through its healthcare AI ecosystem, including MedImageInsight and MedImageParse for medical image embeddings, segmentation, detection, and multimodal analysis.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Siemens Healthineers AG (Germany)
- GE HealthCare (US)
- Koninklijke Philips N.V. (Netherlands)
- Canon Medical Systems Corporation (Japan)
- FUJIFILM Holdings Corporation (Japan)
- Agfa HealthCare (Belgium)
- Carestream Health, Inc. (US)
- Hologic, Inc. (US)
- Merative (US)
- Sectra AB (Sweden)
- Bruker Corporation (US)
- MIM Software Inc. (US)
- Mirada Medical Ltd. (UK)
- Median Technologies (France)
- Aidoc Medical Ltd. (Israel)
- RapidAI, Inc. (US)
- Microsoft Corporation (US)
- Tempus AI, Inc. (US)
- NANO-X Imaging Ltd. (Israel)
- ContextVision AB (Sweden)
- Viz.ai, Inc. (US)
- Avicenna.AI (France)
- Cleerly, Inc. (US)
- Overjet, Inc. (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 4.04 Billion |
| Market Size in 2026 (Value) | USD 4.35 Billion |
| Market Forecast in 2031 (Value) | USD 6.42 Billion |
| CAGR | CAGR of 8.1% from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Type [Integrated Software, Standalone Software], Technology [AI-enabled Technology {Machine Learning, Deep Learning, Computer Vision, Natural Language Processing}, Conventional Technology], Function [Reconstruction & Visualization, Detection & Localization, Segmentation & Analysis, Registration & Comparison, Reporting & Communication, Clinical Decision Support], Image Type [2D Imaging, 3D Imaging, 4D Imaging], Modality [Radiography (X-ray), Computed Tomography (CT) {High-end Slice CT, Mid-end Slice CT, Low-end Slice CT}, Magnetic Resonance Imaging (MRI) {Closed MRI Systems, Open MRI Systems}, Ultrasound Imaging {2D Ultrasound Systems, 3D and 4D Ultrasound Systems, Doppler Imaging}, Nuclear Imaging {Positron Emission Tomography (PET), Single-photon Emission Computed Tomography (SPECT)}, Mammography, Combined/Hybrid Modalities {PET/CT, SPECT/CT, PET/MR}, Others], Therapeutic Area [Cardiology, Oncology, Neurology, Orthopedics, Dental, Obstetrics & Gynecology, Mammography/Breast Imaging, Others], End User [Hospitals, Diagnostic Imaging Centers, Academic & Research Institutions, Other End Users] |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Medical Image Analysis Software Market – AI-enabled Image Analysis & Clinical Workflow |
|
|
| Medical Image Analysis Software Market – Integrated Imaging & AI Workflow Strategy |
|
|
RECENT DEVELOPMENTS
- June 2026 : Aidoc Medical Ltd. (Israel) received FDA Breakthrough Device Designation for First Read, an AI solution designed to analyze chest X-rays and generate preliminary radiology report text. The development extends Aidoc’s clinical AI platform into report drafting to address rising imaging volumes and radiologist workload.
- November 2025 : Siemens Healthineers AG (Germany) introduced new AI-enabled radiology services spanning scheduling, image acquisition, and reporting. The solutions use AI to summarize clinically relevant observations and reduce manual annotation and reporting tasks, strengthening the company’s integrated imaging workflow capabilities.
- November 2025 : GE HealthCare (US) agreed to acquire Intelerad for USD 2.3 billion, combining GE HealthCare’s AI portfolio with Intelerad’s cloud PACS, image sharing, and AI workflow orchestration capabilities. The deal strengthens GE HealthCare’s cloud-first enterprise imaging strategy across hospitals, outpatient centers, and teleradiology.
- February 2025 : RapidAI, Inc. (US) received FDA 510(k) clearance for Lumina 3D, an AI-powered solution that automatically generates 3D reconstructions from CT angiography images. The development reduces manual reconstruction workflows and supports faster visualization of cerebral and vascular anatomy.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
The study involved five major activities to estimate the current size of the medical image analysis software market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of the medical image analysis software market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global medical image analysis software market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
Breakdown of Primary Interviews
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the medical image analysis software market. These methods were also used extensively to estimate the size of various subsegments in the market.
Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the medical image analysis software market.
Market Definition
Medical image analysis software refers to computer-based tools that help clinicians detect, measure, and interpret findings from medical images such as CT, MRI, ultrasound, and X-ray scans. This software aims to reduce radiologists' manual workload while improving diagnostic accuracy and speed. By automating tasks such as abnormality detection and image reporting, hospitals and diagnostic centers can help radiologists focus on complex clinical decisions rather than routine image review.
Key Stakeholders
- Medical imaging equipment manufacturers
- AI software vendors/developers
- Hospitals and diagnostic imaging centers
- Radiologists and healthcare providers
- Academic and research institutions
- Regulatory bodies (e.g., FDA, EMA)
- Healthcare IT/PACS-RIS integration partners
- Cloud service providers
- Venture capitalists and private equity investors
- Business research and consulting service providers
Report Objectives
- To define, describe, and forecast the global medical image analysis software market based on type, technology, function, image type, modality, therapeutic area, end user, and region
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall medical image analysis software market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure profile of the key players of the medical image analysis software market and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To track and analyze competitive developments such as product launches, investments, partnerships, collaborations, acquisitions, expansions, product approvals, and alliances in the medical image analysis software market during the forecast period
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.
The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
- Geographic Analysis: Further breakdown of Latin America, Europe, and the Middle East & Africa medical image analysis software into specific countries.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Medical Image Analysis Software Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Growth opportunities and latent adjacency in Medical Image Analysis Software Market